Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)
NCT00719498
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Resuscitation
Cardiopulmonary
Cardiac Arrest
Interventions
DRUG:
Epo-alpha
Sponsor
Janssen Cilag S.A.S.